CDKN2A and exocrine pancreatic carcinoma: These data parallel those recently reported by Schutte et al (1997), who detected p16INK4a promoter methylation in six out of 17 primary pancreatic carcinoma specimens or pancreatic carcinoma cell lines (35%).